Carregant...
HOW BEST TO USE NEW THERAPIES IN MULTIPLE MYELOMA
Advances in the molecular understanding of myeloma have led to the development of novel agents such as immunomodulatory drugs (IMiDs) and proteasome inhibitors (bortezomib). When used alone, these agents have significant activity against myeloma and responses increase significantly when they are com...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2010
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2867034/ https://ncbi.nlm.nih.gov/pubmed/20359801 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.blre.2010.03.001 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|